Randomized crossover clinical trial comparing the effects of alogliptin and linagliptin on glycemic metabolism in hemodialysis patients with type 2 diabetes mellitus
Not Applicable
- Conditions
- hemodialysis patients with type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000010905
- Lead Sponsor
- Minamisenju hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who has a history of hypersensitivity 2)Pregnant or possibly pregnant women and women on lactation 3)Ineligible patients according to the investigator's judgment 4)The patients who do not agree with this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method